AI assistant
Sending…
Inotiv, Inc. — Director's Dealing 2019
Mar 14, 2019
34595_dirs_2019-03-14_9f1f063b-7601-4fd2-8a4f-3060a3b1942f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2019-03-14
Reporting Person: Sagartz John E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-14 | Common Shares | P | 1400 | $1.94 | Acquired | 3900 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 617625 | Indirect |
Footnotes
F1: The Reporting Person owns 41.175% of the outstanding equity interests of SW Chrysalis, LLC, a Delaware limited liability company, which owns 1,500,000 common shares of the Issuer. The Reporting Person is Co-President and Chief Strategy Officer of SW Chrysalis, LLC.
More from Inotiv, Inc.
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 10
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19